Diatech Diabetes, Inc. logo

Diatech Diabetes, Inc.

Personalizing Insulin Delivery for People with Diabetes

7 employees · est. 2018 · Memphis, United States

VS
Orgenesis Inc. logo

Orgenesis Inc.

Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)

65 employees · est. 2012 · Germantown, United States

Orgenesis Inc. is the older company (2018 vs 2012); Orgenesis Inc. is the larger of the two.

Side-by-Side Comparison

Diatech Diabetes, Inc. Orgenesis Inc.
Founded
2018 2012 older
Headquarters
Memphis, United States Germantown, United States
Employees
7 65 larger
Industry
Health Care, Medical Devices Biotechnology, Health Care, Health and Wellness
Funding Stage
Debt Financing Grant
Total Funding
Not tracked yet $69.12M
Funding Rounds
Not tracked yet 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
MedTech, Insulin Delivery, Insulin Pump, Medical Technology, Medical Device, Smart Sensor, Malfunction Detection, Diabetes, Diabetes Management, Insulin Pump Therapy, Glycemic Control Biotech, Cell Therapy, Gene Therapy, POCare Network, Decentralized Production, Diabetes Treatment, Autologous Insulin Producing (AIP) Cell Transplantation, Beta Cell Replacement, Pancreas Islet Transplantation, Clinical Trials, FDA Guidelines, Molecular And Cellular Approach, Global Biotech Company, Organ Regeneration, Insulin-dependent Diabetes Mellitus
Website
diatechdiabetes.com orgenesis.com
Diatech Diabetes, Inc. logo

About Diatech Diabetes, Inc.

Diatech Diabetes, Inc. develops innovative solutions that empower the lives of patients, families, and communities impacted by diabetes. Having originated from the issues our founders faced with their own diabetes care technology, Diatech Diabetes is inspired to work endlessly towards optimizing the...

Orgenesis Inc. logo

About Orgenesis Inc.

Orgenesis Inc. is a leading global biotech company committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2008. The company's slogan, "Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)", reflects its core mission. In 2020, Orgenesis initiated...

We will tell you when either one moves

BounceWatch watches Diatech Diabetes, Inc. and Orgenesis Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Diatech Diabetes, Inc. and Orgenesis Inc. — by email.

Frequently Asked Questions

Diatech Diabetes, Inc. — Personalizing Insulin Delivery for People with Diabetes. Orgenesis Inc. — Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS). Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Diatech Diabetes, Inc. has raised undisclosed funding while Orgenesis Inc. has raised $69.12M.
Diatech Diabetes, Inc. and Orgenesis Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Diatech Diabetes, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Orgenesis Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes